• Analysts revise AMD price targets as stock hit by muted AI sales forecast

    Advanced Micro Devices shares fell sharply in early Wednesday trading after

  • CVS Health chops 2024 forecast as cost struggles with Medicare Advantage persist

    CVS Health missed first-quarter expectations and chopped its 2024 outlook more than a dollar below Wall Street’s forecast. Shares of the health care giant plunged Wednesday morning after the company said it was still struggling with rising costs from care use in its Medicare Advantage business. Medicare Advantage plans are privately run versions of the federal government’s Medicare program for people age 65 and older.

  • Mastercard's profit beats on strong card spending by U.S. consumers

    Gross dollar volume, the value of all transactions processed on Mastercard's platform, rose 10% to $2.3 trillion. Cross-border volume, which tracks spending on cards outside of the country of their issue, rose 18%. The payments technology industry is gearing up for a seismic shift following Capital One's $35.3 billion deal to acquire Discover Financial.

  • Krispy Kreme® Announces Expansion into Germany

    CHARLOTTE, N.C., May 01, 2024--Krispy Kreme, Inc. (NASDAQ: DNUT) today announced an agreement with restaurant group ISH Kreme to bring one of the world’s most loved sweet treats to Germany. Krispy Kreme® will offer its iconic, fresh doughnuts to German consumers through a network of Krispy Kreme shops starting in Berlin.

  • KFC parent Yum reports surprise drop in global same-store sales on weak demand

    (Reuters) -Yum Brands reported a fall in quarterly global same-store sales on Wednesday, hurt by choppy demand for its KFC and Pizza Hut brands from inflation-weary consumers in the United States as well as in overseas markets. Consumers in the United States are increasingly looking for value-oriented meals in the face of sticky inflation, pushing fast food chains to double down on promotions and offers and on revamping their store and order experiences. Shares of Yum Brands slipped 6% in...

  • J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits

    A subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer. The lawsuits filed against J&J had alleged its talcum powder caused users to develop ovarian cancer, through use for feminine hygiene, or mesothelioma, a cancer that strikes the lungs and other organs. The claims contributed to drop in J&J’s sales of baby powder, prompting the...

  • Global Payments Reports First Quarter 2024 Results

    First quarter 2024 GAAP diluted earnings per share (EPS) of $1.22 and

  • Pfizer lifts profit view on cost cuts, smaller drop in demand for COVID products

    Shares of the U.S. drugmaker have lost 11% of their value this year on worries over its growth after the pandemic as billions of dollars in COVID vaccine and treatment sales evaporated. Pfizer reiterated its annual revenue forecast of $8 billion from the sale of COVID-19 shot Comirnaty and anti-viral treatment Paxlovid. Revenue from Comirnaty, for which it partners with Germany's BioNTech, continues to perform consistently with its expectations, Pfizer said.

  • Pfizer Reports First-Quarter 2024 Results

    NEW YORK, May 01, 2024--Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2024 and raised its Adjusted(3) diluted EPS guidance while maintaining all other components of its 2024 financial guidance(6).

  • CVS cuts 2024 profit forecast as insurance unit faces soaring medical costs

    The U.S. healthcare giant cut its per-share adjusted earnings forecast for 2024 to at least $7.00 from at least $8.30, adding it anticipates the surge in medical procedures at its unit that houses health insurer Aetna to persist. U.S. health insurers have had to contend with rising medical costs over the past few quarters following higher demand for procedures, especially among older adults, that were delayed during the pandemic. CVS said in February it was seeing a rise in hip and knee...

  • Bitcoin slides below $58,000, rattled by tougher Fed rate outlook

    LONDON (Reuters) -Bitcoin fell for a third day on Wednesday, having posted its worst monthly performance in April since late 2022, as investors pulled money out of cryptocurrencies ahead of an interest rate decision by the Federal Reserve later. The value of the world's most traded cryptocurrency fell by nearly 16% in April, as investors booked profits on a sizzling rally that has taken the price to record highs above $70,000. The price of bitcoin is now a full 22% below March's record of...

  • Starbucks revises 2024 guidance, after badly missing its Q2 earnings estimates

    The glass is looking half empty for Starbucks (SBUX) this quarter. For its